All prepro-VIP-derived peptides, except PHI/PHV, are expressed in the female rat anterior pituitary and increased by estrogen.
The expression of VIP precursor products: prepro-VIP(22-79), peptide histidine isoleucine (PHI), peptide histidine valine (PHV), prepro-VIP(111-122), VIP, prepro-VIP(156-170), and prepro-VIP mRNA in the anterior pituitary of estrogen-treated, ovariectomized rats, of ovariectomized controls, and of sham-operated controls was examined. Using radioimmunoassays based on antisera against each of the prepro-VIP sequences, we found that all sequences were expressed and markedly induced by estrogen, except PHI and PHV, which both were undetectable. By immunohistochemistry, it appeared that the number of cells immunoreactive for each of these sequences was increased in the estrogen-treated animals. However, PHI/PHV-immunoreactive cells could not be detected, despite the use of four different PHI antisera with different specificities. Estrogen treatment increased the prepro-VIP mRNA as judged by Northern blotting. In situ hybridization signals for both VIP mRNA and PHI mRNA were observed in few pituitary cells from control animals whereas strong positive signals were observed in a larger number of cells after estrogen treatment. The findings show that estrogen causes activation of the VIP gene expression in anterior pituitary cells, and that the absence of PHI and PHV probably is due to translational or posttranslational events.
University Department of Clinical Biochemistry, Bispebjerg Hospital, Copenhagen, Denmark.
M L
ML
Skakkebaek
B
B
Georg
J D
JD
Mikkelsen
B
B
Ottesen
J
J
Fahrenkrug
D000595:Amino Acid Sequence; D000818:Animals; D015152:Blotting, Northern; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000302:isolation & purification*; D010451:Peptide PHI / Q000302:isolation & purification; D010903:Pituitary Gland, Anterior / Q000033:anatomy & histology / Q000737:chemistry* / Q000187:drug effects*; D011498:Protein Precursors / Q000235:genetics / Q000302:isolation & purification*; D012333:RNA, Messenger / Q000302:isolation & purification; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar; D014660:Vasoactive Intestinal Peptide / Q000235:genetics / Q000302:isolation & purification*
D004967:Estrogens; D010446:Peptide Fragments; D010451:Peptide PHI; D011498:Protein Precursors; D012333:RNA, Messenger; C050123:preprovasoactive intestinal peptide (111-122); D014660:Vasoactive Intestinal Peptide; C055594:preprovasoactive intestinal peptide